Antiplatelet agents in patients with intermediate coronary artery stenosis and deferred revascularization

Back

ESC Premium Access

Antiplatelet agents in patients with intermediate coronary artery stenosis and deferred revascularization

Session: Functional testing in coronary artery disease

Topic: Pharmacotherapy

Speaker: Doctor D. Hong (Seoul, KR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor David Hong

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul (Korea (Republic of))

0 follower

5 more presentations in this session

Clinical value of single projection angiography-derived FFR in non-infarct related artery

Speaker: Assistant Professor S. Lee (Gwangju, KR)

Influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of percutaneous coronary intervention

Speaker: Doctor D. Munhoz (Aalst, BE)

Prognostic implications of microvascular resistance reserve in symptomatic patients with intermediate coronary stenosis

Speaker: Associate Professor J. Lee (Seoul, KR)

VERMONT non-optimised: can baseline diagnostic catheter images be used to measure angiography based CAAS-vFFR?

Speaker: Doctor D. Akrawi (Liverpool, AU)

Fractional flow reserve versus solely angiography-guided revascularisation in coronary artery disease, systematic review and meta-analysis.

Speaker: Mr M. Blaziak (Wroclaw, PL)

Access the full session

Functional testing in coronary artery disease

Speakers: Doctor D. Hong, Assistant Professor S. Lee, Doctor D. Munhoz, Associate Professor J. Lee, Doctor D. Akrawi...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources